scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1018902C |
P356 | DOI | 10.1371/JOURNAL.PONE.0118902 |
P932 | PMC publication ID | 4351983 |
P698 | PubMed publication ID | 25748432 |
P5875 | ResearchGate publication ID | 273325384 |
P50 | author | Xiaodong Fu | Q57046580 |
Tommaso Simoncini | Q38543921 | ||
P2093 | author name string | Jinghe Huang | |
Ping Li | |||
Weiyu Chen | |||
Shuhui Zheng | |||
Yuhong Cui | |||
Yongfu Zhang | |||
P2860 | cites work | 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer | Q50670774 |
2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. | Q53616102 | ||
Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures | Q73035386 | ||
Recognition and neutralization of angiotensins I and II using an artificial nanogel receptor fabricated by ligand specificity determinant imprinting | Q87182553 | ||
Testosterone promotes vascular endothelial cell migration via upregulation of ROCK-2/moesin cascade | Q24337249 | ||
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial | Q29615226 | ||
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase | Q30439814 | ||
Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease | Q30492960 | ||
Acute effects of 2-methoxyestradiol on endothelial aortic No release in male and ovariectomized female rats | Q33543461 | ||
Nongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol | Q34021692 | ||
Molecular insights and therapeutic targets for diabetic endothelial dysfunction | Q34022332 | ||
Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection | Q34502795 | ||
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia | Q34656275 | ||
Cardiovascular pharmacology of estradiol metabolites | Q35600830 | ||
HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis | Q37236532 | ||
Potential vascular actions of 2-methoxyestradiol | Q37385763 | ||
Endothelial dysfunction: the first step toward coronary arteriosclerosis | Q37395620 | ||
Hydrogen sulfide: a new EDRF. | Q37523189 | ||
2-Methoxyestradiol--biology and mechanism of action | Q37705613 | ||
Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders | Q37992099 | ||
2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms | Q38428685 | ||
Quercetin synergizes with 2-methoxyestradiol inhibiting cell growth and inducing apoptosis in human prostate cancer cells | Q39152157 | ||
The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice | Q40221622 | ||
17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release | Q44520623 | ||
2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice. | Q45177122 | ||
Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. | Q45753015 | ||
2-Methoxyestradiol attenuates hypertension and coronary vascular remodeling in spontaneously hypertensive rats | Q46245520 | ||
Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol | Q46384835 | ||
Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement | Q46719150 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0118902 | |
P577 | publication date | 2015-03-06 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | 2-methoxyestradiol induces vasodilation by stimulating NO release via PPARγ/PI3K/Akt pathway | |
P478 | volume | 10 |
Q92159142 | 2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury |
Q53176139 | 2-Methoxyestradiol prevents monocyte adhesion to vascular endothelial cells via downregulation of VCAM-1 expression. |
Q92240832 | A Systems Pharmacology-Based Study of the Molecular Mechanisms of San Cao Decoction for Treating Hypertension |
Q58737878 | Apolipoprotein A1 mimetic peptide ATI-5261 reverses arterial stiffness at late pregnancy and early postpartum in a COMT mouse model of preeclampsia |
Q89179963 | Effects of the Catechol and Methoxy Metabolites of 17β-Estradiol on Nitric Oxide Production by Ovine Uterine Artery Endothelial Cells |
Q92257238 | Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension |
Q38838312 | Inhibition of Autophagy Increases 2-Methoxyestradiol-Induced Cytotoxicity in SW1353 Chondrosarcoma Cells |
Q88379121 | Tumor necrosis factor alfa and interleukin 1 alfa induced phosphorylation and degradation of inhibitory kappa B alpha are regulated by estradiol in endometrial cells |
Search more.